Subclinical Eye Movement Disorders in Patients with Multiple Sclerosis
Neurol 27:614, Solingen,L.D.,et al, 1977
Ocular Torsion and Tilt of Subjective Visual Vertical are Sensitive Brainstem Signs
Ann Neurol 33:292-299, Dieterich,M.&Brandt,T., 1993
The Ocular Manifestations of Multiple Sclerosis, 2, Abnormalities of Eye Movements
JNNP 55:863-868, Barnes,D.&McDonald,W.I., 1992
Divisional Oculomotor Nerve Paresis Caused by Intrinsic Brainstem Disease
Ann Neurol 26:714-718, Ksiazek,S.M.,et al, 1989
Alternating Skew on Lateral Gaze (Bilateral Abducting Hypertropia)
Ann Neurol 23:190-192, Moster,M.L.,et al, 1988
Correlates of Brain-Stem Oculomotor Disorders in Multiple Sclerosis, Magnetic Resonance Imaging
Arch Neurol 43:460-463, Bogousslavsky,J.,et al, 1986
The Clinical Spectrum of Internuclear Ophthalmoplegia in Multiple Sclerosis
Arch Neurol 42:851-855, Muri,R.M.&Meienberg,O., 1985
The One- & -A-Half Syndrome-A Unilateral Disorder of the Pontine Tegmentum:A Study of 20 Cases & Review of the Liter
Neurol 33:971-980, Wall,M.,et al, 1983
Dorsal Midbrain Syndrome in Multiple Sclerosis
Neurol 31:196-198, Slyman,J.F.,et al, 1981
Effects of Induced Hyperthermia on Visual Evoked Potentials & Saccade Parameters in Normal Subjects & MS Pts
JNNP 43:849-852, Bajada,S.,et al, 1980
Changes in Nystagmus on Raising Body Temperature in Clinically Suspected & Proved Multiple Sclerosis
BMJ 2:970, Jestico,J.,et al, 1976
Oculogyric Crisis
In Ocular Differential Diagnosis, Lea & Febiger, Phila. 1975 p. 133, Roy,F.H., 1975
Acquired Pendular Nystagmus with Oscillopsia in Multiple Sclerosis:A Sign of Cerebellar Nuclei Disease
JNNP 37:570, Aschoff,J.C.,et al, 1974
Numb Chin Syndrome
UptoDate.com Sept, Robertson, C.E., 2018
The Useless Hand of Oppenheim
Pract Neurol 17:464-468, Wiblin, L. & Guadagno, J., 2017
Paroxysmal Dystonia as a Manifestation of Multiple Sclerosis
Neurologist 19:132-134, Machado, C.,et al, 2015
Isolated Lingual Dyskinesia in Multiple Sclerosis
JAMA Neurol 72:1196-1197, Park, J.E.,et al, 2015
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology 223:46-56, Bot,J.C.J.,et al, 2002
Optic Neuritis in Multiple Sclerosis: An Update
The Neurologist 6:205-213, Chan,J.W., 2000
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Clinicopath Conf
Acute Multiple Sclerosis, Case Record 42-1990, NEJM 323:1123-1135990., , 1990
Significance of the Argyll Robertson Pupil in Clinical Medicine
Am J Med 86:199-202, Dacso,C.C.&Bortz,D.L., 1989
Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989
Dystonia & Choreoathetosis in Multiple Sclerosis
Arch Neurol 33:590, Bachman,D.S.,et al, 1976
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Narcolepsy
NEJM 288:1156, Zarcone,V., 1973
Isolated Trigeminal Neuropathy-A Report of 16 Cases
Brain 82:391, Spillane,J.,et al, 1959
Localization of Lesions Causing Horner's Syndrome
Arch Ophthamol 44:710, Jaffe,N., 1950
The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024
Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024
Differentiating Multiple Sclerosis from AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease with Imaging
Neurol 100:e308-e323, Cortesa,R.,et al, 2023
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
Neurol 100:e1418-e1432, Cacciaguerra, L.,et al, 2023
Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis
Neurol 97:e414-e422, Jolliffe, E.A.,et al, 2021
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020
Radiologically Isolated Syndrome: A Review for Neuroradiologists
AJNR 41:1542-1549, Hosseiny, M.,et al, 2020
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis
JAMA Neurol 76:1446-1456, Sinnecker, T.,et al, 2019
Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018
Value of the Central Vein Sign at 3T to Differentiate MS from Seropositive NMOSD
Neurol 90:e1183-e1190, Cortese, R.,et al, 2018
Progressive multifocal leukoencephalpathy after fingolimod treatment
Neurol 90:1815-e1821, Berger, J.R.,et al, 2018
Acute coronary syndrome associated with alemtuzumab infusion in multiple sclerosis
Neruol 90:852-854, Ferraro, D.,et al, 2018
Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub Therapy
Neurol 91:e359-e363, Rauer,S.,et al, 2018
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018
Myasthenia Gravis Following Alemtuzumab Therapy for Multiple Sclerosis
Neurol 91:622-624, Midaglia, L.,et al, 2018